Clinical Trial Update: China Stroke Primary Prevention Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for a China stroke primary prevention study sponsored by Shenzhen Ausa Pharmed, investigating primary hypertension; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Shenzhen Ausa Pharmed Co.,Ltd | Conditions: Primary Hypertension | Phase 4 | Status: COMPLETED